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INTRODUCTION/REVIEW OFLITERATURE
Crohn's disease (CD) is a multifactorial polygenic
disease characterised by chronic inflammation of the
gastrointestinal tract (GIT) . It may involve any part
of the GIT. The transmural inflammation
characteristic of Crohn's disease predisposes patients
to the formation of fistulas and up to 50% of patients
with Crohn's disease are affected by fistulas . The
extent of involvement is usually based on
radiological, endoscopic, macroscopic, or routine
histologic examination. These criteria alone
probably underestimate the diffuse nature of the
disease process .
The disease presents in various forms, depending on
its location, its inclination to develop anatomical
complications, or response to treatment. Attempts
have been made to define clinical subgroups on the
basis of disease location, extent (diffuse or
localized), behaviour (primary inflammatory,
fistulating, or fibrostenotic), and by surgical history.
Recently, NOD2/CARD15 has been disclosed as the
first gene associated with CD by two independent
groups and rapidly confirmed by others. Studies in
affected families have shown that affected siblings
frequently present at a similar age and concordance
rates of up to 80% have been reported for disease site,
behaviour and presence of extra intestinal
manifestations of disease . In addition, case-control
association studies have reported genetic
associations with the presence of extra intestinal
manifestations and perianal fistulating disease . In









is the initial manifestation of Crohn's disease. In fact,
the formation of perianal fistulas might precede the
onset of Crohn's disease by several years .
The behaviour of CD is clinically relevant as it is
associated with the development of complications
and need for surgery. The majority of patients present
with non-stricturing, non-penetrating disease at
diagnosis while after 25years the majority harbour
either a stricturing or penetrating pattern. This
changing behaviour may still be determined by both
genetic and environmental factors that may influence
its inclination and speed of evolution. The only
environmental factor clearly associated with CD is
active smoking. Smoking is significantly more
frequent in CD than in healthy controls . Smoking
has also been associated with more aggressive
disease but not with other clinical or biological
characterics, particularly CD behaviour. Besides
smoking, the demographic and clinical characterics
of the disease, including treatment used, may
i n f l u e n c e i t s c h a n g i n g b e h a v i o u r .
Antisaccharomyces cerevisiae antibodies (ASCA)
represent the main serological marker associated
with CD.
The migratory potential of mucosa fibroblasts in
patients with CD has been reported to be less than
that of fibroblasts from control individuals which
suggest that mucosal fibroblasts from patients with
CD might have an impaired ability to respond to
tissue injury. An even greater reduction in migratory
ability has been reported in fibroblasts from fistula
tissue of patients with CD, which suggests a potential
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Crohn's disease (CD) is a multifactorial polygenic disease characterized by chronic inflammation of the
gastrointestinal tract (GIT), often complicated by the development of intestinal strictures and/or formation of
fistulas. Several diagnostic criteria have been proposed, usually relying on clinical, endoscopic, radiological or
histological features.
We report a case of Crohn's disease of the entire colon with rectal sparing presenting with recurrent perianal
fistula that had earlier on been misdiagnosed and treated for other things. The patient was treated successfully
with corticosteroids and aminosalicylates and had since remained stable.
Crohn’s disease, perianal fistula
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destructive colitis involving the entire colon
compatible with Crohn's disease.
A final diagnosis of Crohn's disease was made and
patient was commenced on corticosteroids and
aminosalicylates. He was discharged after three
weeks on admission. His condition remained stable




Endoscopy Picture Showing Perianal
Abscess.
Descending colon showing the narrowed
lumen with the granular appearances of the
mucosa.
Transverse colon showing the narrowed
lumen and the granular appearance of the
mucosa wall.
CASE REPORT
A 23year-old male Asian patient presented with a
recurrent history of abdominal pain, flatulence,
indigestion, fever, arthralgia and swelling of the feet
of three months duration.Abdominal pain was said to
be non-specific, dull and mainly involving the lower
half of the abdomen. The pain was relieved by
passing flatus. Fever was low grade with no chills or
rigors. No associated headache or body aches.
Six years earlier, he had presented at another hospital
with passing drops of blood after defeacation,
swelling in the perianal region for which he had
incision and drainage operation with antibiotics
coverage. Two months later, he had a recurrence of
the perianal swelling and had another incision and
drainage operation done. He had another recurrence
2years later and presented at another hospital where
he was diagnosed to have perianal fistula and had
fistulectomy done. Biopsy of the fistula tract showed
non- specific inflammatory changes.
He remained stable until March 2007, when he
presented at MedIndia Hospital, India with the above
complaints. He admitted to history of loss of weight,
appetite and taste. No history of haematemesis or
melena. No change in bowel habits. He was neither
diabetic nor hypertensive. He admitted to have
smoked heavily (20 pack years) and ingested an
average of four bottles of alcohol per day for the past
fifteen years. These he claimed to have stopped six
months into the present illness.
Examination revealed a chronically ill-looking slim
built young man with low grade fever (T=37.4 C).
He was not pale and not jaundiced and had no
peripheral lymphadenopathy.
Cardiovascular and respiratory examinations were
essentially normal.
Abdomen was soft with mild tenderness in both iliac
fossae; bowel sounds were heard and normal. No
organomegaly. Rectal examination was also normal.
An impression ofAbdominal Tuberculosis to rule out
Inflammatory Bowel Disease (IBD) was made. He
was admitted for further investigations and placed on
intravenous fluids and antibiotics. The results of Full
blood count, Liver function test, Electrolyte, urea &
creatinine were essentially normal.
His Blood group was O while his Haemoglobin
genotype was AA. Hepatitis B surface antigen and
antibodies to hepatitis C were negative. Also HIV
screening was non reactive while Mantoux test was
negative.Abdominal ultrasound was equally normal.
Colonoscopy carried out revealed features of Crohn's
disease of the entire colon (thickened intestinal wall,
narrow intestinal lumen and multiple serpentine
linear ulcers) with rectal sparing and perianal fistula
figures 1- 4. Biopsy specimens were taken from the
caecum, ascending, transverse and descending
colon. Biopsy report showed active, chronic crypt
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Figure 4:
CD is a multifactorial polygenic disease
characterized by chronic inflammation of the GIT,
often complicated by the development of intestinal
strictures and/or the formation of fistulas . Several
diagnostic criteria have been proposed, usually
relying on clinical, endoscopic, radiological or
histological criteria. So defined however, CD is still a
heterogeneous entity. The disease can present in
various forms for example depending on its location,
its inclination to develop anatomical complications
or response to treatment . The association of anal
lesions with Crohn's disease was not described by
Crohn and colleagues in their original paper , but was
reported by Bissel shortly afterwards . It was Morson
and Lockhart-Mummery from St Mark's Hospital in
London who, in 1959, described the sarcoid-like
histological lesions . More than one-third of patients
develop fistulas during their lifetime with the
majority suffering from perianal disease . The
patient under discussion developed recurrent
perianal fistulas and perianal abscesses for which he
had several drainages and fistulectomies. Perianal
fistulization was the initial manifestation of Crohn's
disease in this patient. Patients with colonic
manifestations of Crohn's disease have the highest
incidence of perianal fistulas; this is in keeping with
the findings in this patient (total colonic involvement
with rectal sparing). Despite the prevalence of
fistulas in patients with Crohn's disease, fistula
pathogenesis remains poorly understood. The first
step in the formation of a fistula is generally assumed
to be tissue destruction. The transmural
inflammation that typifies Crohn's disease
predisposes these patients to fistula formation;
luminal bacteria might also have a role in the
development and maintenance of fistulas .
Early development of stricturing or penetrating
behaviour in CD is influenced by disease location,
clinical entity of the disease, and smoking habit but
Ascending colon with the typical









not by NOD2/CARD15 genotype . The smoking
habit of the patient under discussion might have
contributed immensely to the aggressive nature of
this disease in him. The two main independent
associations with change in disease behaviour within
5years after diagnosis were ileal location of the
disease and number of flares per year . Ileal location
was essentially associated with the development of
stricturing disease and was not a discriminant factor
between penetrating disease and non-stricturing non-
penetrating disease when only these two phenotypes
were compared. However, when penetrating disease
was divided into intra abdominal and perianal
disease, ileal location was significantly more frequent
in intra-abdominal than perianal penetrating disease
and is reached in the first subgroups, a frequency
similar to that observed in structuring disease. This
association between stricturing disease or intra-
abdominal penetrating disease and ileal location has
been described in studies of disease behaviour based
on surgical series, irrespective of the duration of the
disease . One explanation for the association with
stricturing disease may be the smaller diameter of the
gut lumen in the ileum than in the colon making
functionally significant strictures more likely to
occur. Another explanation could be the nature of the
immunoinflammatory reaction in the ileum.
Compared with a matched control population, more
patients with CD have been found to smoke tobacco .
Smoking has been recognized as a risk factor for
surgery and recurrence of CD after surgery
particularly in women and heavy smokers . Other
recognized factors for the development of CD are the
type of diet consumed, increased intestinal
permeability, and defects in colonic mucus .
Contrary to expectations, CD does not seem to be
more severe among black patients, who had an earlier
age of diagnosis.
The traditional treatment paradigm in Crohn's disease
is based on a “step- up” approach in which therapies
with the least toxicity are used early, and subsequent
therapies are added due to lack of response or toxicity.
Unfortunately, under this treatment paradigm, agents
with low efficacy such as aminosalicylates are used
for prolonged periods of time while uncontrolled
inflammation results in tissue damage. Patients who
fail to respond to aminosalicylates are then treated
with corticosteroids in the form of prednisolone, or
alternatively with budesonide when disease is limited
to the ileum or right colon. Immunosuppressant
therapy is reserved for those patients with steroid-
refractory or steroid dependent disease. This
approach is endorsed by the American College of
Gastroenterology . Unfortunately, under this current
treatment paradigm, rates of surgical intervention
remain high, with as many as one third of patients
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steroids and with no significant decrease in the need for
surgery over the last several decades despite the earlier
and increasing use of immunomodulators .
The “top-down” approach is currently being advocated
using biologic therapy particularly anti-tumor necrosis
factor (TNF)-alpha. The current goal of top-down
therapy is to avoid steroids and their potential
complications, achieve mucosal healing, and alter the
natural history of the disease. Although steroids have
significant anti-inflammatory activity, which
presumably is responsible for their beneficial effect on
Crohn's disease symptoms, there is evidence that
glucocorticoids contribute to loss of immune
tolerance .
Perianal fistulas in Crohn's disease rarely heal without
treatment, which comprises surgical and medical
therapies. Although some patients only have mild
symptoms or are asymptomatic without a need for
intervention, perianal Crohn's disease may cause severe
morbidity, resulting in disabling and impaired quality
of life. Surgery is usually limited to simple fistula tracts
and drainage of abscesses due to the risk of
incont inence caused by more aggress ive
interventions . Medical therapy represents the
mainstay in the management of perianal fistulas .
Medical management of perianal fistulas includes the
use of systemic antibiotics, immunosuppressive agents
and infliximab . Rapid reduction of fistula drainage by
antibiotics improves the patient's general clinical
condition and may provide a bridging strategy to
azathioprine treatment .
In this case report, the patient was placed on the step-up
approach using corticosteroids (predinisolone) 10mg
three times daily to a maximum of 20mg three times
daily and tailing it down to 5mg daily over the period of
6 months and aminosalicylates 300mg twice daily in
addition to antibiotics (Metronidazole and
ciprofloxacin). He was placed on maintenance
predinisolone 5mg daily and aminosalicylates 300mg
daily for another 3 months. He was followed up for a
total period of 12 months and had since remained stable
with no recurrence of perianal fistulas and abscesses.
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